Adelaide-based genomics biotech Bionomics has appointed a new heavy hitter to its financial team with the signing up of ex-Faulding and ex-Mayne commercialisation expert Lee Craker as new CFO. [ + ]

Expatriate Australian Dr John Sime is headed back to Australia next January, with plans to improve the links between the Australian and the British biotechnology industries. [ + ]

Adelaide-based GroPep has continued to shuck off the disastrous after-effects of its purchase of Biotech Australia by posting a second-half profit for 2002-03. [ + ]

There are four big targets for computer companies when it comes to networked and clustered computers: energy; manufacturing, financial services – and bioinformatics, according to John Davies, general manager of eBiz channels and marketing at Intel. [ + ]

Intel is looking hard at the emerging market of biotech devices. [ + ]

BresaGen (ASX:BGN) intends to spin off its protein pharmaceuticals business and headquarter it in the US, as part of a major restructure. [ + ]

You're a plant geneticist, and you want to extend the range of the world's most important human food crop, rice (Oryza sativa) into cooler regions of the world. [ + ]

A clinical trials program for neuroscience is being established as a platform by the National Neuroscience Facility (NNF) to encourage greater involvement of Australian neuroscience researchers and clinicians in industry-sponsored and investigator driven clinical studies. [ + ]

Capitalising on the successful release of its innovative Pap smear diagnostic into the European market, Polartechnics has dipped a toe into the US investment scene with the appointment of a New York investment banker as strategic advisor. [ + ]

Australian Cancer Technology (AustCancer) has changed tack with new management, a new product line and a move from Perth to Sydney -- all in one day. [ + ]

This year's Eureka prizes were awarded last night in their usual black and red finery at a dinner function at Fox studios in Sydney. [ + ]

An herbal remedy derived from the mukul myrrh tree and used in India to relieve heart symptoms actually raised cholesterol levels instead of lowering them as advertised, researchers said. [ + ]

Intel, chip maker to millions of personal computers across the world, is looking hard at the next emerging market -- biotech devices. [ + ]

It's one thing to design a system that can allow a library of 100,000 compounds to be screened against a protein structure in a day to assess each compound's structural compatibility with the target site. It's another to offer a way to score or rank the compounds according to the best-predicted fit. [ + ]

Melbourne drug delivery company Acrux has successfully completed a Phase I clinical study for its proprietary buspirone metered-dose transdermal spray (MDTS) for the treatment of anxiety. [ + ]